Direct Neuronal Reprogramming of Mouse Astrocytes into Neurons
JoVE Encyclopedia of Experiments
Neuroscience
0 views • 2:12 min • July 8th, 2025
Begin with a multi-well plate containing genetically altered astrocytes. These cells are adhered to a coverslip placed in an astrocyte medium.
These genetically modified cells express transformation factors that force their transition into neurons. This process is called neuronal reprogramming.
Take a neuronal differentiation medium containing specific molecules and the B27 supplement. Together, these components provide essential nutrients and factors for differentiation.
Replace the astrocyte medium with the neuronal differentiation medium.
Incubate the astrocytes for a required duration.
During incubation, the transformation factors expressed by the astrocytes trigger a sequence of molecular events that enable the conversion of an astrocyte into a neuron.
Converted neurons have smaller cell bodies and elongated processes, similar to typical neurons.
Prepare neuronal differentiation medium by adding one milliliter B27 supplement to 49 milliliters of basic culture medium. After 24 to 48 hours, depending on whether cells have been transduced or transfected, replace astrocyte medium with one milliliter neuronal differentiation medium per well. Culture the cells at 37 degrees Celsius with 9% carbon dioxide.
To increase the reprogramming efficiency, supplement the neuronal differentiation medium with Forskolin and Dorsomorphin to a final concentration of 30 micromolar and one micromolar respectively when replacing the astrocyte medium with the differentiation medium. When opting to treat cells with Forskolin and Dorsomorphin, provide a second dose of Dorsomorphin two days after the initial treatment. Add this second treatment directly to the culture medium.
Overview
This article discusses the process of neuronal reprogramming from genetically altered astrocytes. The method involves using a neuronal differentiation medium to facilitate the transformation of astrocytes into neurons.
Key Study Components
Area of Science
- Neuroscience
- Cell Biology
- Neurogenesis
Background
- Astrocytes can be genetically modified to express transformation factors.
- Neuronal reprogramming is a process that converts astrocytes into neurons.
- Specific culture conditions are required for successful differentiation.
- Factors such as B27 supplement and additional compounds can enhance reprogramming efficiency.
Purpose of Study
- To demonstrate the conversion of astrocytes into functional neurons.
- To identify optimal conditions for neuronal differentiation.
- To explore the molecular events involved in neuronal reprogramming.
Methods Used
- Use of a multi-well plate with genetically altered astrocytes.
- Replacement of astrocyte medium with neuronal differentiation medium.
- Incubation of cells at 37 degrees Celsius with 9% carbon dioxide.
- Supplementation of differentiation medium with Forskolin and Dorsomorphin.
Main Results
- Transformed neurons exhibit smaller cell bodies and elongated processes.
- Reprogramming efficiency can be increased with specific supplements.
- Successful neuronal differentiation occurs within 24 to 48 hours.
- Sequential treatment with Dorsomorphin enhances outcomes.
Conclusions
- Genetically altered astrocytes can be effectively reprogrammed into neurons.
- Specific culture conditions and supplements are critical for successful differentiation.
- This method provides insights into neuronal development and potential therapeutic applications.
Frequently Asked Questions
Executive Industry Relevance
Direct neuronal reprogramming of mouse astrocytes enables the generation of neurons from non-neuronal cell types, supporting early discovery efforts in neurobiology and regenerative medicine. This approach provides a controlled system for interrogating neuronal differentiation pathways and evaluating transformation factor efficacy. The method is strategically positioned for target validation and mechanistic de-risking in neurodegenerative disease research portfolios.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables functional assessment of transformation factors in neuronal lineage conversion.
- Supports mechanistic de-risking by clarifying molecular events during astrocyte-to-neuron transition.
- Facilitates predictive confidence in neuronal differentiation protocols for target validation.
Screening & Assay Development
- Provides a reproducible system for preparing neuron-like cells from astrocytes for downstream assays.
- Standardizes differentiation conditions using defined media and supplements for assay consistency.
- Enables quantitative evaluation of reprogramming efficiency and neuronal phenotype acquisition.
Translational & Preclinical Research
- Offers a platform for modeling neuronal differentiation relevant to neurodegenerative disease contexts.
- Supports continuity from in vitro discovery to preclinical validation of neuronal reprogramming strategies.
- Reduces biological ambiguity in cell fate conversion for translational biomarker exploration.
Pipeline & Workflow Integration
This neuronal reprogramming protocol fits within the early discovery to preclinical continuum, enabling hypothesis testing and pathway clarification for neuronal differentiation strategies.
- Discovery Biology: Facilitates interrogation of transformation factor function and molecular pathway activation in astrocyte-to-neuron conversion.
- Screening: Provides standardized, reproducible outputs for evaluating reprogramming efficiency and neuronal marker expression.
- Analytics: Supports quantitative measurement of cell morphology and phenotype acquisition for comparative analysis.
- Translational Research: Aligns with preclinical modeling of neuronal differentiation relevant to disease mechanisms.
- Enterprise Reuse: Establishes a reusable workflow for generating neurons from astrocytes across multiple research programs.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in neuronal differentiation and target validation.
- Operational Value: Delivers standardized, scalable protocols for reproducible cell conversion.
- Strategic Value: Enables informed go/no-go decisions for neuronal reprogramming strategies in early pipelines.
- Portfolio Impact: Supports risk-adjusted prioritization of neuroregeneration and disease modeling projects.
Implementation Considerations
- Requires expertise in genetic modification and neuronal cell culture techniques.
- Needs access to multi-well plate infrastructure and controlled incubation environments.
- Demands cross-team standardization of differentiation media and supplement concentrations.
- May require adaptation for different astrocyte sources or transformation factors.
- Efficiency and phenotype acquisition depend on precise timing and dosing of supplements.
Biopharma FAQs
An Optogenetic Approach for Assessing Formation of Neuronal Connections in a Co-culture System
Related Videos
0 Views
Efficient Neural Differentiation using Single-Cell Culture of Human Embryonic Stem Cells
Related Videos
0 Views
Direct Reprogramming of Mouse Fibroblasts into Melanocytes
Related Videos
0 Views
Electrophysiological Recordings of Reprogrammed Neurons in a Mouse Brain Slice
Related Videos
0 Views
Stereotaxic Injection of Viral Vectors for Glial Cell Reprogramming in a Mouse Model
Related Videos
0 Views
Isolation and Culture of Mouse Cortical Astrocytes
Related Videos
0 Views
Lineage-reprogramming of Pericyte-derived Cells of the Adult Human Brain into Induced Neurons
Related Videos
0 Views
Modeling Astrocytoma Pathogenesis In Vitro and In Vivo Using Cortical Astrocytes or Neural Stem Cells from Conditional, Genetically Engineered Mice
Related Videos
0 Views
Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations
Related Videos
0 Views
In Vivo Direct Reprogramming of Resident Glial Cells into Interneurons by Intracerebral Injection of Viral Vectors
Related Videos
0 Views
Last updated: 29 August 2026